WPG Advisers’s Verona Pharma VRNA Stock Holding History

WPG Advisers’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-154	Closed	-$16.4K	–	1534
2025 Q3	$16.4K	Hold	154	–	–	0.01%	554
2025 Q2	$14.6K	Sell	154 -10	-6%	-$740	0.01%	559
2025 Q1	$10.4K	Sell	164 -34	-17%	-$2.03K	0.01%	632
2024 Q4	$9.2K	Buy	+198	New	+$7.43K	0.01%	655

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

WPG Advisers's VRNA Position: Q4 2025 in Review

WPG Advisers sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 154 shares — an estimated $16.4K sold.

WPG Advisers first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $16.4K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

WPG Advisers reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
WPG Advisers sold 154 Verona Pharma shares in Q4 2025, an estimated $16.4K.
WPG Advisers first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
WPG Advisers's Verona Pharma position peaked at $16.4K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on WPG Advisers's 13F filing for Q4 2025, filed 28 Jan 2026.